Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 2 1

Status

Recruiting 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gynecologic 1Gastrointestinal 1

Conditions

Urinary Bladder Neoplasms 14Non-Muscle Invasive Bladder Neoplasms 10Colorectal Neoplasms 7Appendiceal Neoplasms 6Anus Neoplasms 6Peritoneal Neoplasms 5Carcinoma, Transitional Cell 5Stomach Neoplasms 2Pseudomyxoma Peritonei 2Ovarian Neoplasms 2Uterine Neoplasms 1Urothelial Carcinoma of the Bladder 1Urologic Neoplasms 1Urologic Diseases 1Urogenital Neoplasms 1Urogenital Diseases 1Urinary Bladder Diseases 1Squamous Cell Carcinoma of Head and Neck 1Sarcoma 1Recurrence 1Rectal Neoplasms 1Pleural Neoplasms 1Peritoneal Diseases 1Neoplasms by Site 1Neoplasms 1Neoplasm Metastasis 1Necrosis 1Nasopharyngeal Carcinoma 1Mediastinal Neoplasms 1Male Urogenital Diseases 1

Interventions

Mitomycin 2tislelizumab 1molgramostim 1cryoprecipitate coagulum 1Tacrolimus 1Standard of Care 1Specimen Handling 1Sirolimus 1Nivolumab 1Magnetic Resonance Spectroscopy 1Ipilimumab 1Hyperthermic Intraperitoneal Chemotherapy 1Fluorouracil 1CTLA-4 Antigen 1Alemtuzumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Pseudomyxoma Peritonei × Mitomycin × 1 year × Clear all
NCT04779554 2026-04-01

Flat Dose vs. Weight-based IP Chemotherapy for CRS/HIPEC

University of Kentucky

Phase 2 Recruiting
100 enrolled
GastrointestinalGynecologic

Appendiceal Neoplasms, Peritoneal Neoplasms, Pseudomyxoma Peritonei, Colorectal Neoplasms

NCT06513065 2026-02-19

HIPEC-PMP

University of Southampton

Phase 3 Recruiting
176 enrolled

Pseudomyxoma Peritonei

Data powered by HemOnc (CC BY 4.0) Colophon âš¡